Skip to main content
Signal8
Walsh Jeffrey T. profile photo

Jeffrey T. Walsh

CIK: 0001578251

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Tenaya Therapeutics, Inc. logo
TNYA

Tenaya Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Tenaya Therapeutics, Inc. logo
    TNYA

    Tenaya Therapeutics, Inc.

    May 28, 2026
    Award(A)

    Stock Option (Right to buy)

    Direct
    120K shares-
  • Tenaya Therapeutics, Inc. logo
    TNYA

    Tenaya Therapeutics, Inc.

    May 29, 2025
    Award(A)

    Stock Option (Right to buy)

    Direct
    107.4K shares-
  • Tenaya Therapeutics, Inc. logo
    TNYA

    Tenaya Therapeutics, Inc.

    Oct 18, 2024
    Award(A)

    Stock Option (Right to buy)

    Direct
    34K shares-

1-3 of 3

About Walsh Jeffrey T.

Walsh Jeffrey T. (SEC CIK 0001578251) files insider reports with the SEC as Director of Tenaya Therapeutics, Inc. (TNYA).

Signal8 holds 3 ownership filings by Walsh Jeffrey T., all Form 4s, filed between Oct 21, 2024 and May 29, 2026. Those filings report 3 transactions, from Oct 18, 2024 to May 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Walsh Jeffrey T.'s filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Walsh Jeffrey T.

  • May 28, 2026: Grant or award of TNYA derivative securities (Form 4, code A).
  • May 29, 2025: Grant or award of TNYA derivative securities (Form 4, code A).
  • Oct 18, 2024: Grant or award of TNYA derivative securities (Form 4, code A).

Other insiders filing for Tenaya Therapeutics, Inc. (TNYA)

How to read Form 4 transaction codes